Commercialization: Page 79
-
PharmaVoice Team/PharmaVoice
E-Media
New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: GfK Announces Additions to Marketing Research Portfolio TVG Offers New Forecasting Suite QuestaWeb Offerings Reduce Costs for Importers, Exporters Skila Launches Global Market Access Management Solution StudyManag...
By PharmaVoice Team • July 29, 2009 -
PharmaVoice Team/PharmaVoice
What's New
New Healthcare-related Products, Services, and Companies Featured Briefs: GfK Launches Managed Markets Practice CDM Launches Division Focused on Healthcare Branding Brandtectonics Access Establishes U.S. Office inVentiv Health Rebrands Strategy and Analytics Business GSK, Pfizer Combine HIV Asset...
By PharmaVoice Team • July 29, 2009 -
PharmaVoice Team/PharmaVoice
Who's on the List by Company
Acadia Pharmaceuticals Inc. John Kaiser 68 Acorda Therapeutics Inc. Ron Cohen, M.D. 39 Alnylam Pharmaceuticals John Maraganore, Ph.D. 24 AMR Research Hussain Mooraj 107 Amylin Pharmaceuticals Joseph Martinez 76 Astellas Pharma US Charlotte Berlin 64 AVEO Pharmaceuticals Inc. Tuan Ha-Ngoc 20 Avid ...
By PharmaVoice Team • July 29, 2009 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
The PharmaVOICE 100: 2009 PharmaVOICE is honored to bring you its fifth annual special issue celebrating 100 of the most inspiring individuals in the life-sciences industry. This issue, which is called the feel-good issue of the year, is packed with in-depth profiles showcasing the industry’s bes...
By Taren Grom • July 29, 2009 -
PharmaVoice Team/PharmaVoice
Alliance BUILDERS
Susan Dorfman, Skila Karen J. Hanson, Ph.D., BioStrategy Partners Hussain Mooraj, AMR Research Dominic A. Marasco, Innovex Inc., a Quintiles companyy Bill Meisle, GlaxoSmithKline Building alliances, creating relationships, and making the right connections requires a great deal of skill and savvy,...
By PharmaVoice Team • July 28, 2009 -
PharmaVoice Team/PharmaVoice
The MENTORS
Glen Drummond, Gilead Sciencess Daniel James Schneider, Life Science Commercialization Consultant Peter Marchesini, inVentiv Health Lawrence G. Wright, Ph.D., MedErgy HealthGroup Mentoring takes patience, foresight, and unselfish devotion to furthering the success of others. Creating a corporate ...
By PharmaVoice Team • July 28, 2009 -
PharmaVoice Team/PharmaVoice
The Technologists
Lucia (Lucy) Deus, SupplyScape Corp. Joseph A. Tetzlaff, i3 David J. Pasta, ICON Clinical Research Lucia (Lucy) Deus, SupplyScape Corp. Joseph A. Tetzlaff, i3 David J. Pasta, ICON Clinical Research Cutting-edge thinking and solutions are the hallmark of this dynamic group of individuals who are p...
By PharmaVoice Team • July 28, 2009 -
PharmaVoice Team/PharmaVoice
The Brand CHAMPIONS
As Partner and Chief Strategic Officer at Wishbone/ITP, Judy Capano sets a strong ethical example that’s inspiring to all who work with her. Judy Capano was a Director of Client Services before she turned 30. Problem-Solver • Grounded Name: Judy Capano Current Position: Partner and Chief Strategi...
By PharmaVoice Team • July 28, 2009 -
PharmaVoice Team/PharmaVoice
The ENTREPRENEURS
Michael Beckloff, Beckloff Associates Dr. Joan Bradley, The JB Ashtin Group Faruk Capan, Intouch Solutions Gary Beer, DOV Pharmaceutical, Inc. Ron Cohen, Acorda Therapeutics Inc. Elizabeth Apelles, Greater than One Jaswinder Chadha, marketRx Denise Deman-Williams, Bench International Jay Deakins,...
By PharmaVoice Team • July 28, 2009 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharmaceutical POOL Kurt HARTMAN Dr. Craig HOPKINSON New Hires at Eisai Eisai Inc., a U.S. pharmaceuti cal subsidiary of Japan’s Eisai Co. Ltd., has appointed Kurt Hart man, J.D., senior director of value and access, with responsibility for integrating and aligning Eisai’s focus on reimbursement ...
By PharmaVoice Team • May 25, 2009 -
PharmaVoice Team/PharmaVoice
E-Media
Symyx Grants ACCESS TO MOLECULE INFORMATION The Biotechnology Industry Organization (BIO) has launched the BIO Community (community.convention.bio.org) to provide free resources to biotechnology leaders and professionals in an effort to help them overcome the chal lenges currently facing the indu...
By PharmaVoice Team • May 25, 2009 -
PharmaVoice Team/PharmaVoice
What's New
Vincent Aurentz, executive VP of portfolio devel opment, says this activity complements the compa ny’s tool kit of collaborative approaches to build a highquality portfolio with partners. “The creation of a venture capital fund under lines our commitment to be a best partner for biotech entrepren...
By PharmaVoice Team • May 25, 2009 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Pharma R&D Spending Remains Robust Despite Tough Economy Despite the current economic downturn, pharmaceutical research and development spending continues to play a vital role in the pharmaceutical industry. According to a recent report by CBR Pharma Insights, recent trends indicate a consoli...
By PharmaVoice Team • May 25, 2009 -
PharmaVoice Team/PharmaVoice
Manufacturer Windfall Rebates: Change on the Horizon
The transfer of drug coverage for the dual eligible beneficiaries from Medicaid to Medicare Part D has come under scrutiny by Congress for alleged profit windfalls for manufacturers. The implications of the windfall issue for the pharmaceutical industry are vast. Manufacturers with a large Medica...
By Matthew Warburton and Carleen Kelly • May 25, 2009 -
PharmaVoice Team/PharmaVoice
"Obamaceuticals:" The Good, The Bad, The Controversial, and the Undecided
According to the Deloitte 2009 Industry Outlook report published in December 2008, the Obama Administration could make more changes to the nation’s healthcare system than have occurred since the 1960s. While there are many government policy changes proposed, PharmaVOICE asked leaders from all seg...
By PharmaVoice Team • May 25, 2009 -
PharmaVoice Team/PharmaVoice
David Brennan: Into the Future
BY KIM RIBBINK Into the FUTURE In April, the Pharmaceutical Research and Manufacturers of America (PhRMA) elected AstraZeneca CEO David Brennan as its new chairman, a choice that bodes well for the future of health care and the pharmaceutical companies the organization represents. In his more tha...
By PharmaVoice Team • May 25, 2009 -
PharmaVoice Team/PharmaVoice
Mastering Multichannel Marketing
BY ROBIN ROBINSON KEY TO SUCCESS:Match up channel properties and consistent content with consumer preferences. The key to successful multichannel marketing is to be wherever the consumer is when he or she is ready to receive your message. Easy, right? Not a chance, especially when the consumer is...
By Robin Robinson • May 25, 2009 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Could the tide be turning? The bad and the good We know we are operating in a new economic frontier, when bad news actually passes for good news. A recently released IMS report states that the value of the global pharmaceutical market is expected to grow 2.5% to 3.5% on a constant-dollar basis in...
By Taren Grom • May 23, 2009 -
PharmaVoice Team/PharmaVoice
Synchronizing Communications Educating Physicians, Priming Patients
Medical practice today is a dual process for healthcare providers who are charged with not only maintaining and improving the health and well being of their patients, but operating a business enterprise as well. By understanding the requirements of merging these two visions, it is easy to see why...
By PharmaVoice Team • May 4, 2009 -
PharmaVoice Team/PharmaVoice
Life-Cycle Management of Professional Healthcare Nonpersonal Promotion
two phases — introduction and growth — and possibly into the first year or twoof the maturity phase.After that, the emphasis is onmanaging for profit maximization.This, in turn,usually means disinvesting in promotion — espe cially nonpersonal promotion. In the face of the trends that are constrai...
By PharmaVoice Team • May 4, 2009 -
PharmaVoice Team/PharmaVoice
Defining a Career Path in the New Pharmaceutical Era
Avoiding the Bull’s-Eye When management needs to trim the workforce, there are ways to avoid being the target. The value of an employee increases if he or she has a can-do attitude, is a problem solver, and can react quickly to changes and challenges in the business environment. Binner. AstraZene...
By Robin Robinson • April 27, 2009 -
PharmaVoice Team/PharmaVoice
RX: A Prescription for a New Go-to-Market Strategy
Doing Surgery on the Traditional Sales Model; Those Successful Will Focus on Delivering Science and Service Organizations will have to rationalize the use of a service team approach, instead of working in functional silos, because customers are demanding and expecting more. Celeste Mosby VP, Life...
By Celeste Mosby and Ed Emde • April 27, 2009 -
PharmaVoice Team/PharmaVoice
Making the Sales Rep Essential in Today's Environment
We need to help re-establish the reps’ value for this new era as they are our industry’s front line. It starts with rethinking our sales force strategy, rebranding our reps, and training them to deliver on their brand promise, not just that of the products they sell. George Glatcz, M.S., R.Ph. Pr...
By George Glatcz • April 27, 2009 -
PharmaVoice Team/PharmaVoice
Creating Successful Service Models
Mark Sales, Global Practice Leader, Stakeholder Management TNS Healthcare, A Kantar Health Company Pharmaceutical companies have begun a dramatic transition from product-centric sales models to physician-centric service models. More than 90% of company executives now say they are adopting service...
By Mark Sales • April 27, 2009 -
PharmaVoice Team/PharmaVoice
Showcase
Custom Learning Designs Inc. ePharmaSolutions, Inc. NXLevel Solutions TNS Healthcare Vox Medica, Inc. Wilson Learning Corporation Custom Learning Designs Inc. 375 Concord Ave. Belmont, MA 02478 Phone: 617-489-1702 www.cldinc.com We Create Training Success CLD is a privately held company that was ...
By PharmaVoice Team • April 27, 2009
Previous
